This issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.
TMAs disrupt normal Hemostasis and often present with thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and organ dysfunction. Among these conditions, Thrombotic Thrombocytopenic Purpura (TTP) is one of the most studied and clinically significant subtypes due to its acute onset and high mortality if left untreated.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.
